Simple jQuery Dropdowns

Browsing by Author Wiroj Mankatitham

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Oct-2009Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampinWeerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Wiroj Mankatitham; Aroon Lueangniyomkul; Supeda Thongyen; Boonchuay Eampokarap; Sumonmal Uttayamakul; Pawita Suwanvattana; Samroui Kaewsaard; Kiat Ruxrungtham; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Bamrasnaradura Infectious Diseases Institute
1-Nov-2009Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeWeerawat Manosuthi; Hong Van Tieu; Wiroj Mankatitham; Aroon Lueangniyomkul; Jintanat Ananworanich; Anchalee Avihingsanon; Umaporn Siangphoe; Sukonsri Klongugkara; Sirirat Likanonsakul; Unchana Thawornwan; Bussakorn Suntisuklappon; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University; Columbia University, College of Physicians and Surgeons; The HIV Netherlands Australia Thailand Research Collaboration; South East Asia Research Collaboration with Hawaii
1-Jan-2014CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapyWeerawat Manosuthi; Chonlaphat Sukasem; Aroon Lueangniyomkul; Wiroj Mankatitham; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Feb-2013Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patientsWeerawat Manosuthi; Chonlaphat Sukasem; Aroon Lueangniyomkul; Wiroj Mankatitham; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Feb-2008Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/μLWeerawat Manosuthi; Somnuek Sungkanuparph; Somsit Tansuphaswadikul; Suthat Chottanapund; Wiroj Mankatitham; Sukanya Chimsuntorn; Chayanan Sittibusaya; Visal Moolasart; Achara Chaovavanich; Thailand Ministry of Public Health; Mahidol University; Bamrasnaradura Infectious Diseases Institute
1-Nov-2007Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μLWeerawat Manosuthi; Somnuek Sungkanuparph; Somsit Tansuphaswadikul; Yaowarat Inthong; Wisit Prasithsirikul; Suthat Chottanapund; Wiroj Mankatitham; Sukanya Chimsuntorn; Chayanan Sittibusaya; Visal Moolasart; Nopphanath Chumpathat; Patamavadee Termvises; Achara Chaovavanich; Thailand Ministry of Public Health; Mahidol University
1-May-2011Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective studyWeerawat Manosuthi; Aroon Lueangniyomkul; Wiroj Mankatitham; Sukanya Chimsuntorn; Preecha Tantanathip; Supeda Thongyen; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
15-Jun-2009A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in hiv-infected patients receiving rifampicin: The n<inf>2</inf>r studyWeerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Aroon Lueangniyomkul; Wiroj Mankatitham; Wisit Prasithsirskul; Sunantha Burapatarawong; Supeda Thongyen; Sirirat Likanonsakul; Unchana Thawornwa; Vilaiwan Prommool; Kiat Ruxrungtham; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Chulalongkorn University
11-Oct-2010Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimensWeerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Wisit Prasithsirikul; Preecha Tantanathip; Busakorn Suntisuklappon; Anongnuch Narkksoksung; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Aug-2012Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: Results From the TIME studyWeerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Supeda Thongyen; Sirirat Likanonsakul; Pawita Suwanvattana; Unchana Thawornwan; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University